MCH ADVISORY RESEARCH
Financials

Financial Exchanges & Data

10 companies under coverage.

Coverage

Financial Exchanges & Data


Equity Research

S&P Global Inc (SPGI)

HOLD. 12-month probability-weighted target $397 (-9% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

SPGIEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Nasdaq Inc (NDAQ)

SELL. 12-month probability-weighted target $82 (-17% vs spot). P/E Multiple explains 95% of Monte Carlo outcome variance.

NDAQEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

MSCI Inc (MSCI)

HOLD. 12-month probability-weighted target $550 (-4% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

MSCIEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Morningstar Inc (MORN)

SELL. 12-month probability-weighted target $169 (-22% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

MORNEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Moodys Corporation (MCO)

HOLD. 12-month probability-weighted target $457 (-11% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

MCOEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Intercontinental Exchange Inc (ICE)

SELL. 12-month probability-weighted target $123 (-25% vs spot). P/E Multiple explains 95% of Monte Carlo outcome variance.

ICEEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

FactSet Research Systems Inc (FDS)

SELL. 12-month probability-weighted target $236 (-23% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

FDSEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Coinbase Global Inc (COIN)

SELL. 12-month probability-weighted target $117 (-35% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

COINEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

CME Group Inc (CME)

SELL. 12-month probability-weighted target $217 (-22% vs spot). P/E Multiple explains 95% of Monte Carlo outcome variance.

CMEEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Cboe Global Markets Inc (CBOE)

SELL. 12-month probability-weighted target $235 (-24% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

CBOEEquity ResearchMonte Carlo
25 August 2026Rating: SELL
MCH ADVISORY SERVICES · All research · Not investment advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.19.0 · US-listed · UK English